Valuation: SOPHiA GENETICS SA

Market Cap 687M 610M 570M 519M 979M 66.04B 988M 6.89B 2.67B 33.76B 2.58B 2.52B 108B P/E 2026 *
-8.6x
P/E 2027 * -12.9x
Enterprise Value 687M 610M 570M 519M 979M 66.04B 988M 6.89B 2.67B 33.76B 2.58B 2.52B 108B EV / Sales 2026 *
7.21x
EV / Sales 2027 * 5.79x
Free-Float
88.85%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-3.24%
Current month-3.70%
1 month-2.77%
3 months+50.84%
6 months+60.12%
Current year+72.81%
1 week 7.91
Extreme 7.91
8.73
1 month 7.53
Extreme 7.53
8.73
Current year 4
Extreme 4.005
8.98
1 year 3.75
Extreme 3.75
8.98
3 years 2.46
Extreme 2.46
8.98
5 years 1.68
Extreme 1.685
18.24
10 years 1.68
Extreme 1.685
19.8
Manager TitleAgeSince
Chief Executive Officer 46 2026-06-30
Director of Finance/CFO 64 2024-11-04
Chief Tech/Sci/R&D Officer - 2022-01-09
Director TitleAgeSince
Chairman 47 2026-06-21
Director/Board Member 57 2014-05-31
Chairman 61 2020-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/21/26 Sell

Chief Financial Officer

-774 0.0009%
9/21/26 Sell

Chief Executive Officer

-422 0.0005%
9/14/26 Sell

Chief Technology Officer

-4,000 0.0048%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-3.24%+83.41%+222.80% 687M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.37%-2.58%+6.41%+42.26% 82.33B
Weighted average by Cap. -0.29%-3.27%+1.14%+22.11%

Financials

2026 *2027 *
Net sales 95.23M 84.61M 78.97M 71.98M 136M 9.15B 137M 956M 370M 4.68B 358M 350M 15.02B 119M 105M 98.42M 89.71M 169M 11.41B 171M 1.19B 462M 5.83B 446M 436M 18.72B
Net income -72.06M -64.03M -59.76M -54.47M -103M -6.93B -104M -723M -280M -3.54B -271M -265M -11.37B -48.53M -43.12M -40.24M -36.68M -69.18M -4.67B -69.82M -487M -189M -2.38B -182M -178M -7.65B
Net Debt - -
Logo SOPHiA GENETICS SA
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Employees
415
Date Price Change Volume
26-10-02 US$8.070 +0.50% 748,035
26-10-01 US$8.030 -4.18% 701,004
26-09-30 US$8.380 +0.96% 471,239
26-09-29 US$8.300 -2.24% 315,149
26-09-28 US$8.490 +1.80% 547,679
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
8.070USD
Average target price
9.750USD
Spread / Average Target
+20.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SOPH Stock